Zimmer Biomet Holdings (ZBH) Other Non-Current Liabilities (2009 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Other Non-Current Liabilities came in at $630.7 million in Q1 2026, up 358.02% year-on-year from $137.7 million in Q1 2025, and up 0.73% quarter-over-quarter from $626.1 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Other Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $630.7 million for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 358.02% year-over-year to $630.7 million in Q1 2026; TTM through Mar 2026 was $630.7 million, a 358.02% increase from a year earlier, with the FY2025 full-year figure at $626.1 million, up 246.49% from the prior year.
- Other Non-Current Liabilities climbed to $630.7 million in Q1 2026 per ZBH's latest filing, from $626.1 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $1.2 billion in Q2 2024 and bottomed at $137.7 million in Q1 2025.
- The 5-year median for Other Non-Current Liabilities is $630.7 million (2026), against an average of $633.1 million.
- Across the five-year window, Other Non-Current Liabilities plunged 80.48% in 2024 and surged 358.02% in 2026, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $632.6 million in 2022, then jumped by 46.35% to $925.8 million in 2023, then plunged by 80.48% to $180.7 million in 2024, then surged by 246.49% to $626.1 million in 2025, then climbed by 0.73% to $630.7 million in 2026.
- Per Business Quant, the three latest ZBH Other Non-Current Liabilities figures stand at $630.7 million (Q1 2026), $626.1 million (Q4 2025), and $806.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 630.70 Mn |
| Dec 31, 2025 | 626.10 Mn |
| Sep 30, 2025 | 806.40 Mn |
| Jun 30, 2025 | 878.80 Mn |
| Mar 31, 2025 | 137.70 Mn |
| Dec 31, 2024 | 180.70 Mn |
| Sep 30, 2024 | 1.03 Bn |
| Jun 30, 2024 | 1.21 Bn |
| Mar 31, 2024 | 275.80 Mn |
| Dec 31, 2023 | 925.80 Mn |
| Sep 30, 2023 | 403.10 Mn |
| Jun 30, 2023 | 642.00 Mn |
| Mar 31, 2023 | 637.40 Mn |
| Dec 31, 2022 | 632.60 Mn |
| Sep 30, 2022 | 608.70 Mn |
| Jun 30, 2022 | 591.00 Mn |
| Mar 31, 2022 | 552.50 Mn |
| Dec 31, 2021 | 548.50 Mn |
| Sep 30, 2021 | 596.60 Mn |
| Jun 30, 2021 | 581.60 Mn |